Separation of a targeted cell population from a mixture of impurities represents one of the most decisive steps in downstream processing. Acting as a bridge between upstream expansion and application-specific requirements, selecting an appropriate cell harvesting method can either compromise weeks of work or significantly streamline the workflow. While centrifugation is widely recognized, the scientific and engineering principles behind how we harvest cells extend far beyond this familiar approach.
Downstream processing, inclusive of the steps to harvest cells, can reach up to 80% of total production costs due to extensive material use and need for regulatory compliance (1). © Green Elephant Biotech.
Traditional harvesting of adherent cell lines follows a well-established sequence of steps that has remained largely unchanged for decades. After confirming cell confluence and viability, the culture medium is removed and replaced with phosphate-buffered saline (PBS) to eliminate residual serum. Enzymatic detachment, most commonly using trypsin or accutase, is then applied, followed by incubation.
These steps will vary depending on whether cells are adherent or suspension-based, with larger cultivation vessels introducing additional complexity into the cell culture harvest. Adherent systems often yield relatively cleaner suspensions with fewer debris, enabling more straightforward downstream filtration (2). In contrast, specialized or mixed-cell systems are harder to separate and require more sophisticated cell harvesting methods.
Cell culture harvest represents a critical control point where product degradation and process variability can be introduced — particularly at larger scales, where vessel design becomes application-driven. However, advances in automation and closed processing continuously improve environmental control and harvesting reproducibility, strengthening scalability prospects (3).
This article outlines the interplay between biological diversity and manufacturing constraints that define how scientists harvest cells across research and industrial contexts. While traditional techniques remain relevant, the optimal harvesting approach is ultimately determined by the cell type, process conditions, and fluid properties (2).
Some experiments require purity, some – efficiency, and some – both
If you ever visited or worked at a life science lab, you could not have missed the centrifuge. By exploiting density differences, cells are sedimented at the bottom of a vessel under centrifugal force, enabling rapid and scalable separation. An easy harvesting method to perform, centrifugation aids in maximizing cell quantity over faster time periods (4).
Yet, the efficiency of centrifugation comes with trade-offs. High acceleration forces, especially in industrial-scale centrifuges, can induce shear stress, damaging cell membranes and leading to lysis. The resulting cellular debris can compromise sample purity and downstream processing performance. When maximizing both yield and quality is required, centrifugation alone may not be sufficient (5).
Depth filtration represents a commonly employed alternative, where particles are retained within a porous, cellulose-based matrix depending on their size and density. This cell harvesting method enables simultaneous clarification and capture of target cells, often eliminating the need for additional purification steps (6).
Although filtration is generally gentler on cells and can improve throughput, its applicability is known to be limited by process volume and cost considerations. More refined techniques, such as microfiltration that utilize smaller pore sizes, offer higher purity but introduce trade-offs in efficiency and scalability, focusing their suitability on lower-volume applications (6).
To efficiently harvest specialized cells means to use something more sophisticated than a centrifuge
For specialized cell populations, including but not limited to immune cells, stem cells, and cancer cells, conventional methods are often insufficient. The reason behind this practice is that harvesting these cells frequently involves heterogeneous mixtures, such as blood or dissociated tissue, requiring more selective and targeted separation techniques (6).
Magnetic-activated cell separation (MACS) utilizes antibody-conjugated magnetic particles to selectively bind target cells, enabling rapid and scalable isolation. The efficiency and simplicity of MACS make it a preferred cell harvesting method for larger sample volumes. Meanwhile, fluorescence-activated cell sorting (FACS) differentiates cells based on fluorescent markers, offering high precision and specificity in isolating defined populations (6).
Due to their specificity and high-volume permissibility, FACS and MACS are suitable for immune (from T cells to dendritic cells) and hematopoietic stem cells (e.g., C34+). Finally, buoyancy-activated cell separation or BACS, an emerging technology, employs antibody-functionalized microbubbles that bind target cells and facilitate their separation via buoyancy.
Specifically, the protein-shelled particles bring the targeted cells on the surface, minimizing mechanical stress at an efficiency equivalent to conventional techniques. This gentler cell separation approach supports the clinical need for delicate structures like naïve T cells, which bear the potential for long-lasting treatments in severe malignant disorders (7).
Cell culture harvest at any scale still has room for improvement
At its core, a cell harvesting method for non-specialized cells does not fundamentally change with increasing scale but instead undergoes optimization. At laboratory scale, harvesting allows for direct observation and manual control, enabling fine-tuning of detachment and recovery processes. Reliance on manual processes, however, will inadvertently increase the risk of introducing external decontamination and operator-to-operator variability (5).
At pilot scale, more substantial changes emerge as processes transition from 2D flask-based systems to 3D cultures, often within cylindrical vessels. This shift introduces additional complexity, particularly in enzymatic detachment, where overexposure can result in irreversible cell damage and high-impact batch failure (5).
The introduction of microcarriers in stirred systems does not alleviate these challenges either, as releasing cells from bead surfaces remains technically demanding and introduces variability risks. At commercial scale (i.e., 100 L to 2,000+ L), high cell densities are associated with an increased debris formation, requiring larger filtration areas, which inevitably drive up the overall cost of goods (3).
Independent of scale, finding the right concentration of trypsin or accutase and incubation time to avoid overexposure is considered a “golden standard” problem in cell culture. Increasing cell densities further amplify process demands, reinforcing the need for scalable and controlled harvesting protocols (3).
Selecting an appropriate cell harvesting method requires balancing competing priorities between efficiency and purity, which can be influenced by scale, cell type, and process design. While established approaches like centrifugation and filtration provide robust solutions for many applications, their limitations become more pronounced in high-density and specialized cell mixtures.
At the same time, scaling considerations continue to test how we harvest cells in both research and manufacturing settings. Increasing process volumes, along with the transition to 3D cultures demand greater control over environmental conditions throughout cell culture harvest. As automation and closed processing technologies advance, the ability to optimize harvesting workflows will play a significant role in enabling the production of cellular products and therapies.
Harvesting with CellScrew®:
Our award-winning flagship product, CellScrew®, was designed for a simplified and high-yield harvesting of adherent cells, including iPSCs, HEK, and Vero lines. Available in multiple sizes from 850 to 10,000 cm²-worth of growth surface, CellScrew® minimizes manual handling and is suitable for a range of applications in cell therapy development, cell banking, and vaccine manufacturing.
Looking to learn more? Download Green Elephant Biotech product brochure today!
References:
- What Is the Difference Between Upstream and Downstream Processing? (2026). Jignesh Karakasia, K-JHIL Scientific. Available https://kjhil.com/difference-between-upstream-and-downstream-processing/ (Accessed 27 March 2026).
- Cell Harvesting Steps Separate the Good from the Bad. (2020). Cynthia A. Challener, BioPharm International. Available https://www.biopharminternational.com/view/cell-harvesting-steps-separate-the-good-from-the-bad (Accessed 20 February 2026).
- A Decade of Harvesting Methods. (2012). Maribel Rios, BioProcess International. Available https://www.bioprocessintl.com/chromatography/a-decade-of-harvesting-methods (Accessed 27 March 2026).
- Cell Harvesting: Methods for Isolating Cell Culture from a Growth Medium. (2021). Akadeum, Life Sciences®. Available https://www.akadeum.com/blog/cell-harvesting/ (Accessed 25 March 2026).
- Overcoming Scale-Up Challenges in iPSC Production. (2023). PBS Biotech & Carr Biosystems. Available https://www.carrbiosystems.com/resources/publications/post/overcoming-scale-up-challenges-in-ipsc-production (Accessed 27 March 2026).
- How To Sort Cell Types Using Cell Sorters. (2026). Julia Parker. Available https://int.livhospital.com/how-to-sort-cell-types-using-cell-sorters/ (Accessed 26 March 2026).
- Cell isolation and separation: The different methods and applications. (2025). Abcam Limited. Available https://www.abcam.com/en-us/knowledge-center/cell-biology/cell-isolation-and-separation (Accessed 26 March 2026).
